Fontainea picrosperma
Fontainea picrosperma · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Fontainea picrosperma is a unique botanical species known for its significant medicinal potential. Researchers have identified that both the leaves and roots of this plant contain bioactive compounds. Most notably, it serves as the natural source of the potent chemical tigilanol tiglate. This specific compound is currently being studied for its ability to target and combat various forms of cancer. Consequently, this plant represents a promising frontier in the development of new oncological therapies.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Root
Classification
Common Names
Fontainea picrosperma is a unique botanical species known by several distinct identifiers across different regions. It is widely recognized by its common English name, the blushwood tree. In certain botanical contexts, it is also referred to as Fonténea horkosemenná. These various names reflect the diverse ways the plant is categorized and described by experts and locals alike. Understanding these common names is essential for anyone studying the specific characteristics of this remarkable tree.
Sources: Catalogue of Life (COL)
Taxonomy
Fontainea picrosperma is a unique botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, the plant is classified under the class Equisetopsida. It specifically falls under the order Malpighiales, showcasing its distinct evolutionary lineage. The species is a proud member of the genus Fontainea. Finally, it is nested within the diverse family Euphorbiaceae, which defines its biological characteristics.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Fontainea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Fontainea picrosperma is a distinct plant species characterized by its specific geographical footprint. This botanical specimen is primarily found within the vast region of Australasia. More specifically, its presence is well-documented throughout the diverse landscapes of Australia. Within the continent, the plant shows a notable concentration in the tropical environment of Queensland. Understanding these distribution patterns is essential for studying the ecological niche this species occupies.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Fontainea picrosperma is a robust tree characterized by its impressive stature and growth form. As a self-supporting species, it stands firmly on its own within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Fontainea picrosperma is a medicinally significant plant within the Euphorbiaceae family that serves as the essential source for the diterpene ester tigilanol tiglate. This specific natural product has recently gained clinical importance following its approval as a treatment for canine mast cell tumours. Recent transcriptome analyses have successfully mapped the biosynthetic pathways responsible for producing this compound within the plant's tissues. Research indicates that tigilanol tiglate is found in significantly higher concentrations within the root tissue of the species. This correlation suggests that the initial stages of its biosynthesis occur primarily within the roots, providing a vital resource for future biodiscovery investigations.
Conditions
Fontainea picrosperma serves as a vital medicinal source due to its ability to treat cancer through the isolation of natural products. Specifically, the tree provides the diterpene ester tigilanol tiglate, which has been approved as a treatment for canine mast cell tumours. Researchers have identified that the production of these therapeutic compounds is linked to specific biosynthetic pathways within the plant's tissues. Because laboratory synthesis is not commercially feasible, the plant's medicinal properties must be harnessed through large-scale plantation production. Consequently, understanding the genetic architecture of this species is essential for ensuring a steady supply of its cancer-fighting components.
Preparations
Parts used
Fontainea picrosperma is a medicinally significant plant within the Euphorbiaceae family known for producing the diterpene ester tigilanol tiglate. Recent transcriptome analyses have focused on specific components of the plant, namely its leaves and roots, to understand its biosynthetic pathways. Researchers successfully developed reference transcriptomes by examining the unique genetic expressions found in both the leaf and root tissues. The study revealed that the root tissue contains a significantly higher concentration of tigilanol tiglate compared to the leaves. Ultimately, these findings suggest that the initial stages of this important chemical biosynthesis occur primarily within the roots of Fontainea picrosperma.